跳转至内容
Merck
CN

A-113

Supelco

AH-7921 hydrochloride solution

1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

登录查看公司和协议定价

选择尺寸

关于此项目

经验公式（希尔记法）:
C16H22Cl2N2O · HCl
化学文摘社编号:
41804-96-0
分子量:
365.73
MDL编号:
MFCD27939621
UNSPSC代码:
41116107
NACRES:
NA.24

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

等级

certified reference material

表单

liquid

特点

(Snap-N-Spike®)

包装

ampule of 1 mL

制造商/商品名称

Cerilliant®

药品控制

USDEA Schedule I; Narcotic Licence Schedule E (Switzerland); Pszichotróp anyag / Psychotropic Substance (Hungary), 78/2022. (XII. 28.) BM rendelet

浓度

1.0 mg/mL in methanol (as free base)

技术

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

应用

forensics and toxicology

包装形式

single component solution

储存温度

−20°C

SMILES字符串

ClC1=C(Cl)C=CC(C(NCC2(N(C)C)CCCCC2)=O)=C1.Cl

InChI

1S/C16H22Cl2N2O.ClH/c1-20(2)16(8-4-3-5-9-16)11-19-15(21)12-6-7-13(17)14(18)10-12;/h6-7,10H,3-5,8-9,11H2,1-2H3,(H,19,21);1H

InChI key

GYMKEMDHKUDSBK-UHFFFAOYSA-N

相关类别

一般描述

This certified Snap-N-Spike® Solution is suitable for use as starting material in calibrators and controls for AH-7921 LC-MS or GC/MS methods in clinical toxicology, urine drug testing, or forensic analysis applications. AH-7921 is an opioid designer drug with 80% the potency of morphine when administered orally. First discovered in 2013, AH-7921 is an active ingredient of synthetic cannabis found in Japan.

法律信息

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

警示用语：

Danger

危险分类

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

靶器官

Eyes

储存分类代码

3 - Flammable liquids

WGK

WGK 1

闪点(°F)

49.5 °F - closed cup

闪点(°C)

9.7 °C - closed cup

法规信息

监管及禁止进口产品
此项目有

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

A G Hayes et al.
British journal of pharmacology, 79(3), 731-736 (1983-07-01)
The effects of mu and kappa-opiate receptor agonists were studied in a variety of tests in the mouse designed to correspond to clinical side-effects in man. These included sedation, decrease in pupil diameter, Straub tail, decrease in body temperature, decrease

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持